Otorhinolaryngologic disease

disease
On this page

Also known as disease, ENTdisease, otolaryngologicdisease, otolaryngologicaldisease, otorhinolaryngologicdisease, otorhinolaryngologicaldiseases, ENTdiseases, otolaryngologicdiseases, otolaryngologicaldiseases, otorhinolaryngologicdiseases, otorhinolaryngologicalear, nose and throat disorderear, nose or throat disorderear/nose/throat diseaseENT diseaseENT diseasesotolaryngologic diseaseotolaryngologic diseasesotolaryngologic disorderotolaryngological diseaseotolaryngological diseases

Summary

Otorhinolaryngologic disease (MONDO:0024623) is a disease (an umbrella term covering 40 Mondo subtypes) and 49 clinical trials. Top therapeutic interventions include ciprofloxacin. A subtype of disease by body system or component — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Umbrella term: 40 Mondo subtypes
  • Clinical trials: 49

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical nameotorhinolaryngologic disease
Mondo IDMONDO:0024623
MeSHD010038
NCITC118420
SNOMED CT232208008
UMLSC0395797
MedGen583054
Anatomy (UBERON)UBERON:0007811
Is cancer (heuristic)no

Also known as: disease, ENT · disease, otolaryngologic · disease, otolaryngological · disease, otorhinolaryngologic · disease, otorhinolaryngological · diseases, ENT · diseases, otolaryngologic · diseases, otolaryngological · diseases, otorhinolaryngologic · diseases, otorhinolaryngological · ear, nose and throat disorder · ear, nose or throat disorder · ear/nose/throat disease · ENT disease · ENT diseases · otolaryngologic disease · otolaryngologic diseases · otolaryngologic disorder · otolaryngological disease · otolaryngological diseases (+3 more)

Disease family

An umbrella term covering 40 Mondo subtypes.

Classification path: disease › human disease › disease by body system or component › otorhinolaryngologic disease

Related subtypes (18): disorder of orbital region, integumentary system disorder, musculoskeletal system disorder, urinary system disorder, syndromic disease, auditory system disorder, breast disorder, connective tissue disorder, digestive system disorder, cardiovascular disorder, reproductive system disorder, immune system disorder, nervous system disorder, respiratory system disorder, endocrine system disorder, hematologic disorder, mouth disorder, disorder of visual system

Subtypes (40): bifid nose, autoimmune disease of ear, nose and throat, nasal disorder, atresia of external auditory canal and conductive deafness, external auditory canal atresia-vertical talus-hypertelorism syndrome, laryngeal abductor paralysis, larynx atresia, congenital velopharyngeal incompetence, microtia, congenital tracheal stenosis, laryngeal neuroendocrine neoplasm, arrhinia, laryngotracheal angioma, epignathus, nasolacrimal duct cyst, polyrrhinia, supernumerary nostril, proboscis lateralis, nasal glial heterotopia, nasal ganglioglioma, nasal encephalocele, isolated congenital syngnathia, cysts and fistulae of the face and oral cavity, isolated congenital nasal pyriform aperture stenosis, congenital nasal pyriform aperture stenosis with holoprosencephaly, middle ear anomaly, idiopathic bilateral vestibulopathy, mal de Debarquement, juvenile nasopharyngeal angiofibroma, tracheal agenesis, semicircular canal dehiscence syndrome, hereditary otorhinolaryngologic disease, supratip dysplasia, recurrent respiratory papillomatosis, silent sinus syndrome, anotia, congenital tracheomalacia, disorder of pharynx, disorder of ear, lip and oral cavity squamous cell carcinoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 49.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified42
PHASE23
PHASE42
PHASE1/PHASE22

Top trials by phase / activity

NCTPhaseStatusTitle
NCT03783702PHASE4COMPLETEDPain Control Following Sinus Surgery
NCT04213508PHASE4UNKNOWNType and Frequency of Nasal Irrigation in Rhinosinusitis Patients
NCT06370351PHASE1/PHASE2RECRUITINGA Phase I/II Clinical Trial with SENS-501 in Children Suffering from Severe to Profound Hearing Loss Due to Otoferlin (OTOF) Mutations
NCT00213837PHASE2COMPLETEDReconstruction Implant Bone After Removal Using Porous Titanium Prosthesis
NCT00872209PHASE1/PHASE2COMPLETEDSafety and Efficacy Study of Foam Otic Cipro Compared to a Standard Solution ( Ciloxan - Alcon Labs ) to Treat Acute Otitis Externa
NCT01157819PHASE2COMPLETEDSafety and Efficacy of Once-Daily Dosing of FoamOtic Cipro Compared to Twice-Daily Dosing of Ciloxan Ear Drops in Patients With Acute External Otitis
NCT01359098PHASE2COMPLETEDEfficacy and Safety of Once-Daily Ciprodexa Otic Foam Compared to Twice-daily Ciprodex Ear Drops in Acute Otitis Externa
NCT01524276Not specifiedRECRUITINGProduct Surveillance Registry
NCT04124198Not specifiedACTIVE_NOT_RECRUITINGQuality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma
NCT04547673Not specifiedRECRUITINGTo Develop and Validate a Nasoendoscopic Intelligent Diagnostic System for Nasopharyngeal Carcinoma
NCT05859568Not specifiedENROLLING_BY_INVITATIONBaseline Performance and Fitting Parameters for Sonova Products
NCT06051968Not specifiedACTIVE_NOT_RECRUITINGEffects of an Online Hearing Support for First-time Hearing Aid Users
NCT06258837Not specifiedRECRUITINGTreatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Small Tonsils
NCT06464757Not specifiedRECRUITINGLaryngomalacia, Examinations and Quality of Life in Children Before and After Treatment With Follow-up After 1 Year
NCT06478433Not specifiedNOT_YET_RECRUITINGStudy on the Efficacy and Safety of a Device for Post-op Recovery in Pediatric Adenectomy/Adenotonsillectomy.
NCT07435870Not specifiedNOT_YET_RECRUITINGAnalgesia Nociception Index Monitoring in Trigeminal Cardiac Reflex During Nasal Septoplasty
NCT00001167Not specifiedCOMPLETEDUltrasound Evaluation of Tongue Movements in Speech and Swallowing
NCT00948779Not specifiedCOMPLETEDAntibiotic Education for Children in an Emergency Care Unit
NCT01483937Not specifiedCOMPLETEDEvaluation of a Sensory Enrichment Multimodal Device (SEMD) on Physical Therapy Patients With Disequilibrium
NCT01669278Not specifiedWITHDRAWNEvaluation of Office-Based Sheathed Flexible Nasopharyngoscopy
NCT01738490Not specifiedCOMPLETEDLong-term Stability and Survival Rates of a Novel Oticon Medical Bone Conduction Device Implant
NCT01959152Not specifiedTERMINATEDEvaluation of Hearing Preservation in Adults With Partial Low-Frequency Hearing Implanted With the HiFocus™ Mid-Scala Electrode
NCT02189798Not specifiedTERMINATEDImplantation of the HiRes90K™ Advantage Cochlear Implant With HiFocus™ Mid-Scala and Development of a Combined Electric and Acoustic Stimulation Technology in Adults With Partial Deafness
NCT02315911Not specifiedCOMPLETEDRandomized Control Trials of Surgery for Pediatric OSA
NCT02453633Not specifiedUNKNOWNTheory Based SMS Reminders - Text’s Impact on Patient Attendance
NCT02751658Not specifiedCOMPLETEDTap to Tap, Pathobiome Associates Health Care
NCT02811549Not specifiedCOMPLETEDBenefits of the HiResolution Bionic Ear System in Adults With Asymmetric Hearing Loss
NCT02927652Not specifiedCOMPLETEDPsychiatric Comorbidity
NCT02965183Not specifiedUNKNOWNThe Correlation Between Adenoid Hypertrophy and Body Temperature in Children Before and After Adenoidectomy
NCT03010813Not specifiedCOMPLETEDA Novel Robotic System for Single Port and Natural Orifice Transluminal Endoscopic Surgery
NCT03167463Not specifiedUNKNOWNStentless Endoscopic Transnasal Transseptal Choanoplasty
NCT03243344Not specifiedCOMPLETEDRandomized Assessment of Devices Used to Prevent Post-operative Hemorrhagic Risk in Endonasal Surgery
NCT03501641Not specifiedCOMPLETEDHeart Rate Variability and Cognitive Load on Image-Based Virtual Reality Instructional Design in Otolaryngology
NCT03695666Not specifiedCOMPLETEDA Completed-cycle Local Audit of Patient Load in the SHO-led ENT Casualty Clinic
NCT03793816Not specifiedCOMPLETEDTonsillectomy Using BiZact™ - a Randomized Side-controlled Clinical Trial
NCT03931226Not specifiedCOMPLETEDImpact of Spa Treatments on the Consumption of Care in Children
NCT04151264Not specifiedCOMPLETEDInfluence of the Hypotension Probability Index on Intraoperative and Postoperative Hypotension in ENT- and OM-Surgery
NCT04162405Not specifiedUNKNOWNTinnitus in Patients With and Without Sensorineural Hearing Loss
NCT04237207Not specifiedCOMPLETEDClinical Evaluation of a Cochlear Implant Sound Processor
NCT04464304Not specifiedCOMPLETEDVirtual Reality for Postoperative Pain Management

Drugs tested across these trials (top 30)

MoleculeMax phaseTrials referencing
CIPROFLOXACIN43